Company / R&D Expense
Bluejay Diagnostics, Inc. R&D Expense History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$5.7M
FY2023
5-year range
$4.2M / $5.7M
FY2022-FY2023
Trend
+37.6%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$6M in FY2023.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, r&d expense increased 37.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $5.7M | +37.6% |
| FY2022 | $4.2M | - |
As of FY2023 · SEC Form 10-K · Last checked Jun 22, 2026